First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies
Imaging Technology
JUNE 15, 2023
Ken Herrmann , Section Editor of the Journal of Nuclear Medicine , said: “The clinical translation of a fluorine-18 PET tracer that targets CD8 would be a significant breakthrough in the field, not just for patients but also in the world of drug development.” Lancet Oncology 2023; 24(3): e133-e143.
Let's personalize your content